Regenxbio (RGNX) FCF Margin (2014 - 2025)

Regenxbio's (RGNX) quarterly FCF Margin came in at 200.52% in Q4 2025, down 5301.0% year-on-year from 3.86% in Q4 2024, and down 2.18% quarter-over-quarter from 196.24% in Q3 2025.

Regenxbio (RGNX) FCF Margin (2014 - 2025) Analysis & Trends

Regenxbio's FCF Margin history runs 12 years deep, the most recent figure standing at 200.52% for Q4 2025.

  • On a quarterly basis, FCF Margin fell 5301.0% year-over-year to 200.52% in Q4 2025; TTM through Dec 2025 was 76.46%, a 13216.0% increase from a year earlier, with the FY2025 full-year figure at 80.87%, up 12592.0% from the prior year.
  • FCF Margin declined to 200.52% in Q4 2025 per RGNX's latest filing, from 196.24% in the prior quarter.
  • Across five years, FCF Margin topped out at 102.54% in Q4 2021 and bottomed at 447.99% in Q1 2023.
  • The 5-year median for FCF Margin is 198.37% (2022), against an average of 194.59%.
  • Across the five-year window, FCF Margin sank 32879 bps in 2021 and jumped 40250 bps in 2025, its largest moves.
  • Year by year, FCF Margin stood at 102.54% in 2021, then tumbled by 216 bps to 119.38% in 2022, then decreased by 14 bps to 136.57% in 2023, then declined by 8 bps to 147.51% in 2024, then tumbled by 36 bps to 200.52% in 2025.
  • Per Business Quant, the three latest RGNX FCF Margin figures stand at 200.52% (Q4 2025), 196.24% (Q3 2025), and 216.29% (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 10.45%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 43.35%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.53%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Regenxbio 528.62 Mn 298.55 Mn 21.22 Mn -200.52%

Historic Data

Download Data
DateValue
Dec 31, 2025 -200.52%
Sep 30, 2025 -196.24%
Jun 30, 2025 -216.29%
Mar 31, 2025 37.46%
Dec 31, 2024 -147.51%
Sep 30, 2024 -173.31%
Jun 30, 2024 -197.19%
Mar 31, 2024 -365.04%
Dec 31, 2023 -136.57%
Sep 30, 2023 -210.30%
Jun 30, 2023 -199.93%
Mar 31, 2023 -447.99%
Dec 31, 2022 -119.38%
Sep 30, 2022 -199.54%
Jun 30, 2022 -153.94%
Mar 31, 2022 -301.01%
Dec 31, 2021 102.54%
Sep 30, 2021 -356.32%
Jun 30, 2021 -157.46%
Mar 31, 2021 -253.31%